Summary
In 59 cases of primary human renal cell carcinoma (RCC), cross-resistance and collateral susceptibility patterns were determined in an MTT microculture assay. Concomitantly, the glutathione (GSH) content and the enzymatic activity of γ-glutamyl transpeptidase (GGT) were measured as distinct resistance characteristics. Resistance or chemoresponse towards Vinca alkaloids and anthracyclines were found to be highly coincident, suggesting that the classical multidrug resistance mechanism is active in human RCC. Strong resistance to platinum complexes combined with relative sensitivity to bleomycin was significantly associated with elevated glutathione levels, providing evidence for another pathway instigating chemoresistance. In contrast, despite substantial enzymatic activity, GGT effects revealed no correlation to the chemoresistance pattern. This result implies that it is the GSH-linked binding and reduction potential rather than the GGT-associated transportation capacity that has an impact on the expression of chemoresistance in human RCC.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alley MC, Scudero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48:589
Antholine WE, Petering DH, Saryan LA, Brown CE (1981) Interactions among iron (II) bleomycin, Lewis bases, and DNA. Proc Natl Acad Sci USA 78:7517
Arrick BA, Nathan CF (1984) Glutathione metabolism as a determinant of therapeutic efficacy. Cancer Res 44:4224
Bech-Hansen NT, Till JE, Ling V (1976) Pleiotropic phenotype of colchicine resistant CHO cells. Cross resistance and collateral sensitivity. J Cell Physiol 88:23
Freedman JH, Horwitz SB, Peisach J (1982) Reduction of copper(II)bleomycin: a model for in vivo drug activity. Biochemistry 21:2203
Goldstein LJ, Galski H, Fojo A, Willingham W, Lai SL, Gazdar A, Pirker R, Green A, Crist W, Brodeur GM, Lieber M, Cossman J, Gottesman MM, Pastan I (1989) Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 81:116
Gottesman MM, Pastan I (1988) The multidrug transporter, a double-edged sword. J Biol Chem 263:12163
Griffith OW, Meister A (1979) Translocation of intracellular glutathione to membrane-bound γ-glutamyl transpeptidase as a discrete step in the γ-glutamyl cycle: glutathionuria after inhibition of transpeptidase. Proc Natl Acad Sci USA 76:268
Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Statist 6:65
Kanamaru H, Kakehi Y, Yoshia O, Nakanishi S, Pastan I, Gottesman MM (1989) MDR 1 RNA levels in human renal cell carcinomas: correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explants. J Natl Cancer Inst 81:844
Lowry OH, Rosebrough NJ, Farr AL, Randall RL (1951) Protein measurement with the Folin-phenol reagent. J Biol Chem 193:265
Meister A (1988) Glutathione metabolism and its selective modification. J Biol Chem 263:17205
Mickisch G, Fajta S, Keilhauer G, Schlick E, Tschada R, Alken P (1990) Chemosensitivity testing of primary human renal cell carcinoma by a tetrazolium based microculture assay (MTT). Urol Res 18:131
Mickisch G, Bier H, Bergler W, Bak M, Tschada R, Alken P (1990) P-170 glycoprotein, glutathione and associated enzymes in relation to chemoresistance of primary human renal cell carcinomas. Urol Intern 45:170
Mickisch G, Kössig J, Keilhauer G, Schlick E, Tschada R, Alken P (1990) Effects of calcium antagonists in multidrug resistant primary human renal cell carcinomas. Cancer Res 50:3670
Mickisch G, Merlino GT, Galski H, Gottesman MM, Pastan I (1991) Transgenic mice that express the human multidrug resistance gene in bone marrow enable a rapid identification of agents that reverse drug resistance. Proc Natl Acad Sci USA 88:547
Morrow CS, Cowan KH (1988) Mechanisms and clinical significance of multidrug resistance. Oncology 2:55
Moscow JA, Cowan KH (1988) Multidrug resistance. J Natl Cance Inst 80:14
Mossman T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55
Pieters R, Huishmans DR, Leyva A, Veerman AJP (1989) Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukemia. Br J Cancer 59:217
Price P, McMillan TJ (1990) Use of the tetrazolium assay in measuring the response of human tumor cells to ionizing radiation. Cancer Res 50:1392
Slater TF, Sawyer B, Sträuli UD (1963) Studies on succinatetetrazolium reductase systems: points of coupling of four different tetrazolium salts. Biochem Biophys Acta 77:383
Tietze F (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Application to mammalian blood and other tissues. Anal Biochem 27:502
Torti FM (1983) Treatment of metastatic renal cell carcinoma. In: Torti FM (ed) Urologic cancer: chemotherapeutic principles and management. Springer, Berlin Heidelberg New York, p 123
Tsuruo T, Hamilton TC, Louie KG, Behrens BC, Young RC, Ozols RF (1986) Collateral susceptibility of adriamycin-, melphalan-and cisplatin-resistant human ovarian tumor cells to bleomycin. Jpn J Cancer Res (Gann) 77:941
Twentyman PR, Walls GA, Wright KA (1984) The response of tumor cells to radiation and cytotoxic drugs — a comparison of clonogenic and isotope uptake assays. Br J Cancer 50:625
Twentyman PR, Fox NE, Rees JKH (1989) Chemosensitivity testing of fresh leukemia cells using the MTT colorimetric assay. Br J Haematol 71:19
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mickisch, G., Fajta, S., Bier, H. et al. Cross-resistance patterns related to glutathione metabolism in primary human renal cell carcinoma. Urol Res 19, 99–103 (1991). https://doi.org/10.1007/BF00368184
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00368184